Michael J. Rider - 01 Apr 2025 Form 4 Insider Report for RESMED INC (RMD)

Signature
Michael J. Rider, Global General Counsel and Secretary
Issuer symbol
RMD
Transactions as of
01 Apr 2025
Net transactions value
-$14,263
Form type
4
Filing time
03 Apr 2025, 12:59:42 UTC
Previous filing
04 Mar 2025
Next filing
03 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $14,263 -64 -0.72% $222.86 8,846 01 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024.